Plasma levels of the β-carbolines harman and norharman in Parkinson's disease
- 1 December 1995
- journal article
- research article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 92 (6), 451-454
- https://doi.org/10.1111/j.1600-0404.1995.tb00479.x
Abstract
Several lines of evidence suggest that endogenous and exogenous toxins may play a major role in the pathogenesis of Parkinson's disease (PD). In vivo aromatic β‐carbolines, like harman or norharman, may easily be formed by cyclization of indoleamines with e.g. aldehydes. Because of the structural similarity to MPTP, β‐carbolines have been proposed as endogenous toxins. For further elucidation of the role of β‐carbolines in neurodegenerative disorders, harman and norharman plasma levels were measured in 36 patients with PD and compared to an age‐ and sex‐matched control group. Plasma levels of norharman in PD were significantly higher compared to the control group. Harman in the plasma of Parkinsonian patients was also elevated compared to controls, but this difference was not significant. Correlation of β‐carbolines with plasma levels of L‐dopa, oral doses of bromocriptine and selegiline in treated Parkinsonian patients showed no significant results. On the one hand these results may suggest a possible role of β‐carbolines in the pathophysiological processes initiating PD, by, e.g., inducing mitochondrial respiratory inhibition like MPP +. One may speculate, however, that elevated levels of norharman and harman are due to an endogenous upregulation caused by unknown metabolic processes.Keywords
This publication has 12 references indexed in Scilit:
- Occurence and partition of the β-carboline norharman in rat organsLife Sciences, 1993
- Potential bioactivated neurotoxicants, N-methylated β-carbolinium ions, are present in human brainBrain Research, 1993
- Novel S‐Adenosylmethionine‐Dependent Indole‐N‐Methylation of β‐Carbolines in Brain Particulate FractionsJournal of Neurochemistry, 1992
- Similar Inhibition of Mitochondrial Respiration by 1-Methyl-4-Phenyl-Pyridinium (MPP+) and by a Unique N-Methylated Beta-Carboline Analogue, 2,9?Dimethyl?Norharman (2,9Me2NH)Annals of the New York Academy of Sciences, 1992
- Norharman, a normal body constituentThe Lancet, 1992
- β-Carbolines and Tetrahydroisoquinolines: Detection and Function in MammalsPlanta Medica, 1991
- Plasma Norharman (β‐Carboline) Levels are Elevated in Chronic AlcoholicsAlcohol, Clinical and Experimental Research, 1991
- Mitochondrial respiratory inhibition by N-methylated beta-carboline derivatives structurally resembling N-methyl-4-phenylpyridine.Proceedings of the National Academy of Sciences, 1990
- Striatal dopaminergic toxicity following intranigral injection in rats of 2-methyl-norharman, a β-carbolinium analog of N-methyl-4-phenylpyridinium ion (MPP+)Neuroscience Letters, 1989
- Determination of l-DOPA and 3-O-methyl DOPA in human plasma by extraction using C18 cartridges followed by high-performance liquid chromatographic analysis with electrochemical detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1986